These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 34912073

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A, Cremers JF, Kliesch S, Riek S, Junker K, Mohamed SA, Anheuser P, Belge G, Dieckmann KP.
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
    [Abstract] [Full Text] [Related]

  • 4. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A.
    J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
    [Abstract] [Full Text] [Related]

  • 5. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J, Leão R, Gillis AJM, van den Berg A, Anson-Cartwright L, Atenafu EG, Kuhathaas K, Chung P, Hansen A, Bedard PL, Jewett MAS, Warde P, O'Malley M, Sweet J, Looijenga LHJ, Hamilton RJ.
    Eur Urol Oncol; 2021 Jun; 4(3):483-491. PubMed ID: 33288479
    [Abstract] [Full Text] [Related]

  • 6. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
    van Agthoven T, Eijkenboom WMH, Looijenga LHJ.
    Cell Oncol (Dordr); 2017 Aug; 40(4):379-388. PubMed ID: 28612337
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A, Hennig F, Ikogho R, Hammel J, Anheuser P, Wülfing C, Belge G, Dieckmann KP.
    Urol Int; 2018 Aug; 100(4):470-475. PubMed ID: 29698973
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.
    Int J Mol Sci; 2018 Oct 12; 19(10):. PubMed ID: 30321995
    [Abstract] [Full Text] [Related]

  • 13. Clinical utility of plasma miR-371a-3p in germ cell tumors.
    Mego M, van Agthoven T, Gronesova P, Chovanec M, Miskovska V, Mardiak J, Looijenga LHJ.
    J Cell Mol Med; 2019 Feb 12; 23(2):1128-1136. PubMed ID: 30536846
    [Abstract] [Full Text] [Related]

  • 14. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G.
    Eur Urol; 2017 Feb 12; 71(2):213-220. PubMed ID: 27495845
    [Abstract] [Full Text] [Related]

  • 15. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
    Belge G, Dumlupinar C, Nestler T, Klemke M, Törzsök P, Trenti E, Pichler R, Loidl W, Che Y, Hiester A, Matthies C, Pichler M, Paffenholz P, Kluth L, Wenzel M, Sommer J, Heinzelbecker J, Schriefer P, Winter A, Zengerling F, Kramer MW, Lengert M, Frey J, Heidenreich A, Wülfing C, Radtke A, Dieckmann KP.
    Clin Cancer Res; 2024 Jan 17; 30(2):404-412. PubMed ID: 37967143
    [Abstract] [Full Text] [Related]

  • 16. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
    Kılınç MT, Göger YE, Özkent MS, Kılıç Ö, Okur Altındaş B, Yıldırım MS, Karalezli G.
    Urol J; 2024 Jun 09; 21(4):242-249. PubMed ID: 38629199
    [Abstract] [Full Text] [Related]

  • 17. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.
    J Urol; 2015 Jan 09; 193(1):331-7. PubMed ID: 25046619
    [Abstract] [Full Text] [Related]

  • 18. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
    Dieckmann KP, Hennig F, Anheuser P, Gehrckens R, Viehweger F, Wülfing C, Belge G.
    Urol Int; 2021 Jan 09; 105(1-2):21-26. PubMed ID: 33049748
    [Abstract] [Full Text] [Related]

  • 19. Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels.
    Fankhauser CD, Wettstein MS, Christiansen AJ, Rothermundt C, Cathomas R, Kaufmann E, Sigg S, Templeton AJ, Hirschi-Blickenstorfer A, Lorch A, Gillessen S, Beyer J, Hermanns T.
    Urol Oncol; 2024 Dec 09; 42(12):455.e9-455.e13. PubMed ID: 39261117
    [Abstract] [Full Text] [Related]

  • 20. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S, Heinzelmann J, Bohle RM, Weber G, Stöckle M, Junker K, Heinzelbecker J.
    Andrology; 2020 Nov 09; 8(6):1687-1698. PubMed ID: 32530514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.